翻訳と辞書 Words near each other ・ Digama burmana ・ Digama costimacula ・ Digama culta ・ Digama daressalamica ・ Digama fasciata ・ Diffusion flame ・ Diffusion hardening ・ Diffusion layer ・ Diffusion limited enzyme ・ Diffusion line ・ Diffusion map ・ Diffusion Monte Carlo ・ Diffusion MRI ・ Diffusion of innovations ・ Diffusion of responsibility ・ Diffusion Pharmaceuticals ・ Diffusion Pictures ・ Diffusion process ・ Diffusion pump ・ Diffusion transistor ・ Diffusion wavelets ・ Diffusion welding ・ Diffusion-controlled reaction ・ Diffusion-limited aggregation ・ Diffusionless transformation ・ Diffusiophoresis ・ Diffusive gradients in thin films ・ Diffusivity ・ Diffuson ・ Diffutidin Dictionary Lists mini英和辞書 mini和英辞書 Webster 1913 Latin-English FOLDOC Wikipedia English ウィキペディア

翻訳と辞書　辞書検索 [ 開発暫定版 ] スポンサード リンク Diffusion Pharmaceuticals ： ウィキペディア英語版 Diffusion Pharmaceuticals Diffusion Pharmaceuticals LLC is a biotechnology and drug development company based in Charlottesville, Virginia, U.S. It was co-founded in 2001 by American life sciences entrepreneur David Kalergis and University of Virginia Chemical Engineering Professor John L. Gainer.〔 Gainer is the inventor of the company’s platform technology of oxygen diffusion-enhancing compounds and its lead drug, trans sodium crocetinate (TSC). TSC acts to increase the rate at which oxygen moves through blood plasma by the process of diffusion, a phenomenon that forms the basis for the company's name. TSC and other oxygen diffusion-enhancing compounds, including bipolar trans carotenoid salts (the subclass to which TSC belongs), have been investigated by Diffusion Pharmaceuticals for treatment of conditions associated with reduced oxygen availability in tissues (hypoxia).〔〔 == Research activities == Gainer invented the concept of oxygen diffusion-enhancing compounds and its specific embodiment, TSC, while a Professor of Chemical Engineering at the University of Virginia. He secured the first patent on the molecule and its uses in 2000. Before TSC's invention, he and colleagues conducted research on the effects of oxygen diffusion-enhancing compounds in various animal disease models, including atherosclerosis, arthritis and cancer. At that time, crocetin, a naturally occurring carotenoid compound, was the focus of their research. With the invention of TSC, their research turned to the potential use of this synthetic oxygen diffusion-enhancing compound for the improved treatment of hemorrhagic shock (shock caused by the loss of a large volume of blood) on the battlefield.〔〔 This research, which was supported financially by the United States Office of Naval Research (ONR), was conducted in Gainer’s University of Virginia laboratory. Following the company's formation by Kalergis and Gainer in 2001, both ONR and private funding was obtained, enabling company researchers to set up their own laboratory and, along with collaborators, perform further preclinical studies into uses of TSC in the treatment of hemorrhagic shock and other hypoxic conditions, such as ischemic stroke, central nervous system (CNS) disorders, and cancer.〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Diffusion Pharmaceuticals」の詳細全文を読む スポンサード リンク 翻訳と辞書 : 翻訳のためのインターネットリソース Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.